MetaADEDB 2.0 @ LMMD
Oxycodone
(MUZQPDBAOYKNLO-RKXJKUSZSA-N)
Structure
SMILES
COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)CCC1=O)C.Cl
Molecular Formula:
C18H22ClNO4
Molecular Weight:
351.825
Log P:
1.7881
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
59
CAS Number(s):
124-90-3
Synonym(s)
1.
Oxycodone
2.
Dihydrohydroxycodeinone
3.
Oxiconum
4.
Oxycodeinon
5.
Dihydrone
6.
Dinarkon
7.
Eucodal
8.
Oxycodone Hydrochloride
9.
Oxycone
10.
Oxycontin
11.
Pancodine
12.
Theocodin
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Toxicity to various agentsFAERS: 1119
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 308
Canada Vigilance: 12
Canada Vigilance
US FAERS
3Completed SuicideFAERS: 138US FAERS
4OverdoseFAERS: 121
Canada Vigilance: 7
Canada Vigilance
US FAERS
5NauseaFAERS: 120
Canada Vigilance: 3
Canada Vigilance
US FAERS
6Drug abuseFAERS: 109
Canada Vigilance: 36
Canada Vigilance
US FAERS
7PainFAERS: 100
Canada Vigilance: 3
Canada Vigilance
US FAERS
8VomitingFAERS: 99
Canada Vigilance: 2
Canada Vigilance
US FAERS
9Respiratory arrestFAERS: 97US FAERS
10Cardiac ArrestFAERS: 83US FAERS
11SomnolenceFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Accidental overdoseFAERS: 78
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Drug DependenceFAERS: 76
Canada Vigilance: 44
Canada Vigilance
US FAERS
14Drug abuserFAERS: 73US FAERS
15MalaiseFAERS: 63
Canada Vigilance: 3
Canada Vigilance
US FAERS
16ConstipationFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
17HeadacheFAERS: 60US FAERS
18Drug withdrawal syndromeFAERS: 55
Canada Vigilance: 9
Canada Vigilance
US FAERS
19Inadequate analgesiaFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
20DizzinessFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Multiple drug overdoseFAERS: 51US FAERS
22DeliriumFAERS: 45US FAERS
23Drug diversionFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
24Feeling abnormalFAERS: 42
Canada Vigilance: 2
Canada Vigilance
US FAERS
25Pharmaceutical product complaintFAERS: 42US FAERS
26Unresponsive to stimuliFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
27PruritusFAERS: 33US FAERS
28Product quality issueFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
29Product substitution issueFAERS: 30US FAERS
30Medication ErrorFAERS: 28US FAERS
31FatigueFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
32Drug dispensing errorFAERS: 25US FAERS
33PneumoniaFAERS: 25US FAERS
34Respiratory FailureFAERS: 25US FAERS
35LethargyFAERS: 24US FAERS
36TremorFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Unevaluable eventFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Abdominal discomfortFAERS: 22US FAERS
39Therapeutic response unexpected with drug substitutionFAERS: 22US FAERS
40UrticariaFAERS: 22US FAERS
41Accidental drug intake by childFAERS: 19US FAERS
42Euphoric moodFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
43Intentional drug misuseFAERS: 19US FAERS
44PoisoningFAERS: 19US FAERS
45AnxietyFAERS: 18US FAERS
46Depressed Level of ConsciousnessFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
47nervous system disorderFAERS: 18US FAERS
48Abdominal PainFAERS: 17US FAERS
49Drug toxicityFAERS: 17US FAERS
50Weight decreasedFAERS: 17US FAERS
51Back PainFAERS: 16US FAERS
52Intentional product use issueFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Malignant neoplasm progressionFAERS: 16US FAERS
54Respiratory DepressionFAERS: 16US FAERS
55Suicide attemptFAERS: 16US FAERS
56Mental status changesFAERS: 15US FAERS
57Autonomic nervous system imbalanceFAERS: 14US FAERS
58Chest PainFAERS: 14US FAERS
59HypotensionFAERS: 14US FAERS
60Myocardial InfarctionFAERS: 14US FAERS
61Cerebrovascular accidentFAERS: 13US FAERS
62General physical health deteriorationFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
63Product formulation issueFAERS: 13US FAERS
64AgitationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
65AmnesiaFAERS: 12US FAERS
66AstheniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Drug screen negativeFAERS: 12US FAERS
68Memory impairmentFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Accidental exposureFAERS: 11US FAERS
70Incorrect dose administeredFAERS: 11US FAERS
71Incorrect route of drug administrationFAERS: 11US FAERS
72Product taste abnormalFAERS: 11US FAERS
73DisorientationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
74TachycardiaFAERS: 10US FAERS
75Wrong technique in product usage processFAERS: 10US FAERS
76BedriddenFAERS: 9US FAERS
77Brain DeathFAERS: 9US FAERS
78BronchitisFAERS: 9US FAERS
79Drug level increasedFAERS: 9US FAERS
80DysgeusiaFAERS: 9US FAERS
81DyspepsiaFAERS: 9US FAERS
82HypersensitivityFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Pulmonary EmbolismFAERS: 9US FAERS
84Pulmonary HypertensionFAERS: 9US FAERS
85Pulmonary granulomaFAERS: 9US FAERS
86Wrong technique in drug usage processFAERS: 9US FAERS
87DysarthriaFAERS: 8US FAERS
88HypoxiaFAERS: 8US FAERS
89Intentional product misuseFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
90SepsisFAERS: 8US FAERS
91Ventricular FibrillationFAERS: 8US FAERS
92BronchopneumoniaFAERS: 7US FAERS
93CardiomegalyFAERS: 7US FAERS
94DehydrationFAERS: 7US FAERS
95Drug administered to patient of inappropriate ageFAERS: 7US FAERS
96Drug prescribing errorFAERS: 7US FAERS
97Drug screen positiveFAERS: 7US FAERS
98ExcoriationFAERS: 7US FAERS
99Product physical issueFAERS: 7US FAERS
100Right ventricular failureFAERS: 7US FAERS
101Accidental deathFAERS: 6US FAERS
102Altered state of consciousnessFAERS: 6US FAERS
103ArthralgiaFAERS: 6US FAERS
104ArthritisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Blood glucose increasedFAERS: 6US FAERS
106ChillsFAERS: 6US FAERS
107Cold sweatFAERS: 6US FAERS
108EndocarditisFAERS: 6US FAERS
109Feeling jitteryFAERS: 6US FAERS
110FormicationFAERS: 6US FAERS
111Inappropriate schedule of drug administrationFAERS: 6US FAERS
112LeukoencephalopathyFAERS: 6US FAERS
113Loss of personal independence in daily activitiesFAERS: 6US FAERS
114Multiple drug overdose accidentalFAERS: 6US FAERS
115MyalgiaFAERS: 6US FAERS
116NephrolithiasisFAERS: 6US FAERS
117Respiratory distressFAERS: 6US FAERS
118Spinal fusion surgeryFAERS: 6US FAERS
119SyncopeFAERS: 6US FAERS
120Toxic leukoencephalopathyFAERS: 6US FAERS
121Chest discomfortFAERS: 5US FAERS
122ChromaturiaFAERS: 5US FAERS
123DependenceFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Diabetes MellitusFAERS: 5US FAERS
125FibromyalgiaFAERS: 5US FAERS
126FlatulenceFAERS: 5US FAERS
127Hepatitis CFAERS: 5US FAERS
128Hip surgeryFAERS: 5US FAERS
129HydrocephalusFAERS: 5US FAERS
130HypersomniaFAERS: 5US FAERS
131Intentional misuseFAERS: 5US FAERS
132Limb injuryFAERS: 5US FAERS
133No adverse eventFAERS: 5US FAERS
134PallorFAERS: 5US FAERS
135PalpitationsFAERS: 5US FAERS
136SciaticaFAERS: 5US FAERS
137Urinary tract infectionFAERS: 5US FAERS
138Victim of homicideFAERS: 5US FAERS
139Visual ImpairmentFAERS: 5US FAERS
140Activities of daily living impairedFAERS: 4US FAERS
141Acute Lung InjuryFAERS: 4US FAERS
142Alanine Aminotransferase IncreasedFAERS: 4US FAERS
143AngerFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
144ArthropathyFAERS: 4US FAERS
145Aspartate Aminotransferase IncreasedFAERS: 4US FAERS
146AsthmaFAERS: 4US FAERS
147Biliary dilatationFAERS: 4US FAERS
148Blood creatine phosphokinase increasedFAERS: 4US FAERS
149Blood pH decreasedFAERS: 4US FAERS
150Cardiac DeathFAERS: 4US FAERS
151CyanosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
152Drug ToleranceFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
153ErythemaFAERS: 4US FAERS
154HomicideFAERS: 4US FAERS
155InfluenzaFAERS: 4US FAERS
156Intervertebral Disc DegenerationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
157Joint swellingFAERS: 4US FAERS
158Lyme DiseaseFAERS: 4US FAERS
159Mental impairmentFAERS: 4US FAERS
160Multiple drug overdose intentionalFAERS: 4US FAERS
161NasopharyngitisFAERS: 4US FAERS
162NervousnessFAERS: 4US FAERS
163Oropharyngeal painFAERS: 4US FAERS
164Paroxysmal sympathetic hyperactivityFAERS: 4US FAERS
165Polysubstance abuseFAERS: 4US FAERS
166Product counterfeitFAERS: 4US FAERS
167Product dispensing errorFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
168QuadriplegiaFAERS: 4US FAERS
169RestlessnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Sudden Cardiac DeathFAERS: 4US FAERS
171SwellingFAERS: 4US FAERS
172Therapeutic response unexpectedFAERS: 4US FAERS
173ToothacheFAERS: 4US FAERS
174Transaminases increasedFAERS: 4US FAERS
175Urinary RetentionFAERS: 4US FAERS
176VertigoFAERS: 4US FAERS
177Wrong drug administeredFAERS: 4US FAERS
178AbasiaFAERS: 3US FAERS
179AkathisiaFAERS: 3US FAERS
180Arthropod biteFAERS: 3US FAERS
181Atrial FibrillationFAERS: 3US FAERS
182Blood alkaline phosphatase increasedFAERS: 3US FAERS
183Blood chloride increasedFAERS: 3US FAERS
184Blood glucose decreasedFAERS: 3US FAERS
185Blood immunoglobulin E increasedFAERS: 3US FAERS
186Blood potassium increasedFAERS: 3US FAERS
187Blood testosterone decreasedFAERS: 3US FAERS
188Blood urea increasedFAERS: 3US FAERS
189Bone painFAERS: 3US FAERS
190Breakthrough PainFAERS: 3US FAERS
191CataractFAERS: 3US FAERS
192CatatoniaFAERS: 3US FAERS
193CellulitisFAERS: 3US FAERS
194Dental cariesFAERS: 3US FAERS
195Depressed moodFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
196DisabilityFAERS: 3US FAERS
197Drug administration errorFAERS: 3US FAERS
198Drug effect incompleteFAERS: 3US FAERS
199Drug exposure during pregnancyFAERS: 3US FAERS
200Drug exposure via breast milkFAERS: 3US FAERS
201Ejection Fraction DecreasedFAERS: 3US FAERS
202Emotional disorderFAERS: 3US FAERS
203Emotional distressFAERS: 3US FAERS
204Extra dose administeredFAERS: 3US FAERS
205Eye painFAERS: 3US FAERS
206Feeling ColdFAERS: 3US FAERS
207Gastrointestinal PainFAERS: 3US FAERS
208Gastrointestinal motility disorderFAERS: 3US FAERS
209GlaucomaFAERS: 3US FAERS
210HepatitisFAERS: 3US FAERS
211HypercapniaFAERS: 3US FAERS
212HypophagiaFAERS: 3US FAERS
213IleusFAERS: 3US FAERS
214Impaired gastric emptyingFAERS: 3US FAERS
215Incorrect route of product administrationFAERS: 3US FAERS
216InflammationFAERS: 3US FAERS
217Injury asphyxiationFAERS: 3US FAERS
218Medication residueFAERS: 3US FAERS
219PhotophobiaFAERS: 3US FAERS
220PneumonitisFAERS: 3US FAERS
221Product administration errorFAERS: 3US FAERS
222Product comminglingFAERS: 3US FAERS
223Product label confusionFAERS: 3US FAERS
224Product size issueFAERS: 3US FAERS
225RhabdomyolysisFAERS: 3US FAERS
226Rheumatoid ArthritisFAERS: 3US FAERS
227Sinus TachycardiaFAERS: 3US FAERS
228SinusitisFAERS: 3US FAERS
229SluggishnessFAERS: 3US FAERS
230Sudden deathFAERS: 3US FAERS
231Throat irritationFAERS: 3US FAERS
232ThrombosisFAERS: 3US FAERS
233TinnitusFAERS: 3US FAERS
234Tongue discomfortFAERS: 3US FAERS
235Ventricular arrhythmiaFAERS: 3US FAERS
236Visual disturbanceFAERS: 3US FAERS
237AcidosisFAERS: 2US FAERS
238AcneFAERS: 2US FAERS
239Acute respiratory failureFAERS: 2US FAERS
240Ankle FractureFAERS: 2US FAERS
241AnorexiaFAERS: 2US FAERS
242Anoxic EncephalopathyFAERS: 2US FAERS
243Antibody test positiveFAERS: 2US FAERS
244Apparent deathFAERS: 2US FAERS
245AsphyxiaFAERS: 2US FAERS
246Atrial FlutterFAERS: 2US FAERS
247Autonomic neuropathyFAERS: 2US FAERS
248Benign Prostatic HyperplasiaFAERS: 2US FAERS
249Blood alcohol increasedFAERS: 2US FAERS
250Blood creatinine increasedFAERS: 2US FAERS
251Blood sodium decreasedFAERS: 2US FAERS
252Blood urine presentFAERS: 2US FAERS
253Brain HypoxiaFAERS: 2US FAERS
254CarcinomaFAERS: 2US FAERS
255Central nervous system lesionFAERS: 2US FAERS
256Cerebral ventricle dilatationFAERS: 2US FAERS
257Cholecystitis infectiveFAERS: 2US FAERS
258Clostridium difficile infectionFAERS: 2US FAERS
259Coronary Artery DiseaseFAERS: 2US FAERS
260CycloplegiaFAERS: 2US FAERS
261CystitisFAERS: 2US FAERS
262CystoceleFAERS: 2US FAERS
263DementiaFAERS: 2US FAERS
264DermatitisFAERS: 2US FAERS
265Diffuse alveolar damageFAERS: 2US FAERS
266DiplopiaFAERS: 2US FAERS
267DiscomfortFAERS: 2US FAERS
268Drug effect delayedFAERS: 2US FAERS
269Drug effect variableFAERS: 2US FAERS
270Dry skinFAERS: 2US FAERS
271DysphoniaFAERS: 2US FAERS
272DysuriaFAERS: 2US FAERS
273Economic problemFAERS: 2US FAERS
274EncephalitisFAERS: 2US FAERS
275EpilepsyFAERS: 2US FAERS
276Exposure during breast feedingFAERS: 2US FAERS
277Flank PainFAERS: 2US FAERS
278Growth retardationFAERS: 2US FAERS
279HemiplegiaFAERS: 2US FAERS
280Impaired driving abilityFAERS: 2US FAERS
281IncoherentFAERS: 2US FAERS
282InfectionFAERS: 2US FAERS
283Intentional self-injuryFAERS: 2US FAERS
284Intestinal ObstructionFAERS: 2US FAERS
285Joint injuryFAERS: 2US FAERS
286Large intestine perforationFAERS: 2US FAERS
287LeukocytosisFAERS: 2US FAERS
288Limb operationFAERS: 2US FAERS
289Lobar PneumoniaFAERS: 2US FAERS
290LymphomaFAERS: 2US FAERS
291Macular degenerationFAERS: 2US FAERS
292MalabsorptionFAERS: 2US FAERS
293Maternal exposure during pregnancyFAERS: 2US FAERS
294Metastatic NeoplasmFAERS: 2US FAERS
295Mood swingsFAERS: 2US FAERS
296Muscle tightnessFAERS: 2US FAERS
297Musculoskeletal stiffnessFAERS: 2US FAERS
298MydriasisFAERS: 2US FAERS
299MyoclonusFAERS: 2US FAERS
300Neck PainFAERS: 2US FAERS
301Neonatal hypotensionFAERS: 2US FAERS
302Nerve Root CompressionFAERS: 2US FAERS
303Nerve injuryFAERS: 2US FAERS
304Neuropsychiatric syndromeFAERS: 2US FAERS
305Night sweatsFAERS: 2US FAERS
306ParanoiaFAERS: 2US FAERS
307Paranoid Personality DisorderFAERS: 2US FAERS
308Pelvic discomfortFAERS: 2US FAERS
309Polysubstance dependenceFAERS: 2US FAERS
310Poor quality drug administeredFAERS: 2US FAERS
311Poor quality sleepFAERS: 2US FAERS
312Post procedural complicationFAERS: 2US FAERS
313Prescription drug used without a prescriptionFAERS: 2US FAERS
314Product availability issueFAERS: 2US FAERS
315Product container seal issueFAERS: 2US FAERS
316Product contaminationFAERS: 2US FAERS
317Product tamperingFAERS: 2US FAERS
318Product use in unapproved indicationFAERS: 2US FAERS
319Pulmonary FibrosisFAERS: 2US FAERS
320Pulmonary congestionFAERS: 2US FAERS
321Quality of life decreasedFAERS: 2US FAERS
322RectoceleFAERS: 2US FAERS
323RetchingFAERS: 2US FAERS
324Septic ShockFAERS: 2US FAERS
325Sinus headacheFAERS: 2US FAERS
326SoporFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Spinal column stenosisFAERS: 2US FAERS
328StuporFAERS: 2US FAERS
329Suspected counterfeit productFAERS: 2US FAERS
330TheftFAERS: 2US FAERS
331Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Thermal burnFAERS: 2US FAERS
333Tooth ExtractionFAERS: 2US FAERS
334Unresponsive to verbal stimuliFAERS: 2US FAERS
335Ventricular hypertrophyFAERS: 2US FAERS
336Victim of child abuseFAERS: 2US FAERS
337Victim of sexual abuseFAERS: 2US FAERS
338YawningFAERS: 2US FAERS
339AbscessFAERS: 1US FAERS
340Accidental exposure to productFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
341Acute kidney injuryFAERS: 1US FAERS
342AdenocarcinomaFAERS: 1US FAERS
343AgeusiaFAERS: 1US FAERS
344Agonal death struggleFAERS: 1US FAERS
345AkinesiaFAERS: 1US FAERS
346Alcohol poisoningFAERS: 1US FAERS
347AlopeciaFAERS: 1US FAERS
348Ammonia increasedFAERS: 1US FAERS
349Analgesic drug level above therapeuticFAERS: 1US FAERS
350Analgesic drug level decreasedFAERS: 1US FAERS
351Anaphylactic shockFAERS: 1US FAERS
352Animal biteFAERS: 1US FAERS
353AnosmiaFAERS: 1US FAERS
354AnuriaFAERS: 1US FAERS
355ApathyFAERS: 1US FAERS
356AphagiaFAERS: 1US FAERS
357AphasiaFAERS: 1US FAERS
358ArteriosclerosisFAERS: 1US FAERS
359ArthrodesisFAERS: 1US FAERS
360Artificial crown procedureFAERS: 1US FAERS
361AsterixisFAERS: 1US FAERS
362AtherosclerosisFAERS: 1US FAERS
363Atypical pneumoniaFAERS: 1US FAERS
364Automatic bladderFAERS: 1US FAERS
365Back disorderFAERS: 1US FAERS
366BallismusFAERS: 1US FAERS
367Base excess decreasedFAERS: 1US FAERS
368Bipolar DisorderFAERS: 1US FAERS
369Bladder spasmFAERS: 1US FAERS
370BlindnessFAERS: 1US FAERS
371Blood albumin decreasedFAERS: 1US FAERS
372Blood amylase increasedFAERS: 1US FAERS
373Blood bicarbonate abnormalFAERS: 1US FAERS
374Blood creatine increasedFAERS: 1US FAERS
375Blood fibrinogen increasedFAERS: 1US FAERS
376Blood magnesium abnormalFAERS: 1US FAERS
377Blood phosphorus increasedFAERS: 1US FAERS
378Blood potassium abnormalFAERS: 1US FAERS
379Blood pressure immeasurableFAERS: 1US FAERS
380Body temperature fluctuationFAERS: 1US FAERS
381Bone scan abnormalFAERS: 1US FAERS
382BradycardiaFAERS: 1US FAERS
383Brain ContusionFAERS: 1US FAERS
384BronchospasmFAERS: 1US FAERS
385Burning sensationFAERS: 1US FAERS
386Cardiac ablationFAERS: 1US FAERS
387Cardiac neoplasm unspecifiedFAERS: 1US FAERS
388Cardiac valve ruptureFAERS: 1US FAERS
389Cardiovascular insufficiencyFAERS: 1US FAERS
390Carpal Tunnel SyndromeFAERS: 1US FAERS
391Cataract operationFAERS: 1US FAERS
392Cerebral InfarctionFAERS: 1US FAERS
393Cerebral disorderFAERS: 1US FAERS
394Chemical injuryFAERS: 1US FAERS
395ChemotherapyFAERS: 1US FAERS
396CholelithiasisFAERS: 1US FAERS
397ColectomyFAERS: 1US FAERS
398ColitisFAERS: 1US FAERS
399Contraindicated drug administeredFAERS: 1US FAERS
400Cor pulmonaleFAERS: 1US FAERS
401Counterfeit drug administeredFAERS: 1US FAERS
402Counterfeit product administeredFAERS: 1US FAERS
403CryingFAERS: 1US FAERS
404Culture positiveFAERS: 1US FAERS
405CystFAERS: 1US FAERS
406Deep Vein ThrombosisFAERS: 1US FAERS
407Delusional disorder, unspecified typeFAERS: 1US FAERS
408Device fastener issueFAERS: 1US FAERS
409Diabetes InsipidusFAERS: 1US FAERS
410Diabetic ulcerFAERS: 1US FAERS
411Diffuse Axonal InjuryFAERS: 1US FAERS
412DiplegiaFAERS: 1US FAERS
413Disease ProgressionFAERS: 1US FAERS
414Disease recurrenceFAERS: 1US FAERS
415DrowningFAERS: 1US FAERS
416Drug dispensed to wrong patientFAERS: 1US FAERS
417Drug dose titration not performedFAERS: 1US FAERS
418Drug ineffective for unapproved indicationFAERS: 1US FAERS
419Drug level decreasedFAERS: 1US FAERS
420Drug physiologic incompatibilityFAERS: 1US FAERS
421Drug withdrawal convulsionsFAERS: 1US FAERS
422Drug-disease interactionFAERS: 1US FAERS
423DysphemiaFAERS: 1US FAERS
424Electroencephalogram abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
425Endodontic procedureFAERS: 1US FAERS
426Epigastric discomfortFAERS: 1US FAERS
427Erectile dysfunctionFAERS: 1US FAERS
428Expired product administeredFAERS: 1US FAERS
429Eye irritationFAERS: 1US FAERS
430Febrile NeutropeniaFAERS: 1US FAERS
431Feeding disorder of infancy OR early childhoodFAERS: 1US FAERS
432Feeling of body temperature changeFAERS: 1US FAERS
433FlushingFAERS: 1US FAERS
434Food aversionFAERS: 1US FAERS
435Foreign body aspirationFAERS: 1US FAERS
436Foreign body embolismFAERS: 1US FAERS
437FractureFAERS: 1US FAERS
438Gait inabilityFAERS: 1US FAERS
439Gastric ulcerFAERS: 1US FAERS
440GastroschisisFAERS: 1US FAERS
441General symptomFAERS: 1US FAERS
442Gingival RecessionFAERS: 1US FAERS
443GliosisFAERS: 1US FAERS
444GlossectomyFAERS: 1US FAERS
445Gram stain positiveFAERS: 1US FAERS
446Hepatic EncephalopathyFAERS: 1US FAERS
447Hepatic congestionFAERS: 1US FAERS
448HepatomegalyFAERS: 1US FAERS
449HerniaFAERS: 1US FAERS
450HyperacusisFAERS: 1US FAERS
451Hypertrophic CardiomyopathyFAERS: 1US FAERS
452Hypoaesthesia facialFAERS: 1US FAERS
453HypokinesiaFAERS: 1US FAERS
454HypoparathyroidismFAERS: 1US FAERS
455Hyporesponsive to stimuliFAERS: 1US FAERS
456Hypothalamic pituitary adrenal axis suppressionFAERS: 1US FAERS
457Hypothalamo-pituitary disorderFAERS: 1US FAERS
458HypoventilationFAERS: 1US FAERS
459HysterectomyFAERS: 1US FAERS
460Impaired work abilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
461Inappropriate PrescribingFAERS: 1US FAERS
462Inappropriate schedule of product administrationFAERS: 1US FAERS
463Incorrect drug administration durationFAERS: 1US FAERS
464Intercepted drug administration errorFAERS: 1US FAERS
465Intercepted drug dispensing errorFAERS: 1US FAERS
466Intercepted medication errorFAERS: 1US FAERS
467Intervertebral disc disorderFAERS: 1US FAERS
468Intestinal resectionFAERS: 1US FAERS
469Joint dislocation postoperativeFAERS: 1US FAERS
470Joint stiffnessFAERS: 1US FAERS
471LaryngitisFAERS: 1US FAERS
472LaryngospasmFAERS: 1US FAERS
473Ligament injuryFAERS: 1US FAERS
474Lip and/or oral cavity cancerFAERS: 1US FAERS
475Lower respiratory tract infectionFAERS: 1US FAERS
476Lumbar radiculopathyFAERS: 1US FAERS
477Lung InjuryFAERS: 1US FAERS
478LymphadenopathyFAERS: 1US FAERS
479MacroglossiaFAERS: 1US FAERS
480Malignant ascitesFAERS: 1US FAERS
481Medical device implantationFAERS: 1US FAERS
482Medical device removalFAERS: 1US FAERS
483Meniscus injuryFAERS: 1US FAERS
484Metabolic acidosisFAERS: 1US FAERS
485MetastasisFAERS: 1US FAERS
486Middle insomniaFAERS: 1US FAERS
487Mitral Valve StenosisFAERS: 1US FAERS
488Mucocutaneous flap necrosisFAERS: 1US FAERS
489Muscle RigidityFAERS: 1US FAERS
490Muscle SpasticityFAERS: 1US FAERS
491Musculoskeletal PainFAERS: 1US FAERS
492Musculoskeletal discomfortFAERS: 1US FAERS
493Myocardial fibrosisFAERS: 1US FAERS
494Nail bed infectionFAERS: 1US FAERS
495NarcolepsyFAERS: 1US FAERS
496Nasogastric output abnormalFAERS: 1US FAERS
497Neonatal complications of substance abuseFAERS: 1US FAERS
498NeuritisFAERS: 1US FAERS
499Neurological examination abnormalFAERS: 1US FAERS
500Nonspecific reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
501Opiates positiveFAERS: 1US FAERS
502Oral pruritusFAERS: 1US FAERS
503OsteomyelitisFAERS: 1US FAERS
504PO2 decreasedFAERS: 1US FAERS
505Pain of skinFAERS: 1US FAERS
506Pancreatic carcinomaFAERS: 1US FAERS
507PancreatitisFAERS: 1US FAERS
508Panic DisorderFAERS: 1US FAERS
509ParaplegiaFAERS: 1US FAERS
510ParesisFAERS: 1US FAERS
511Patient uncooperativeFAERS: 1US FAERS
512Peptic UlcerFAERS: 1US FAERS
513Peripheral arterial occlusive diseaseFAERS: 1US FAERS
514Peripheral swellingFAERS: 1US FAERS
515PeritonitisFAERS: 1US FAERS
516Personality ChangeFAERS: 1US FAERS
517PetechiaeFAERS: 1US FAERS
518Pharmaceutical product counterfeitFAERS: 1US FAERS
519PneumoperitoneumFAERS: 1US FAERS
520PneumothoraxFAERS: 1US FAERS
521PolyneuropathyFAERS: 1US FAERS
522Pregnancy test false positiveFAERS: 1US FAERS
523Prescription form tamperingFAERS: 1US FAERS
524PresyncopeFAERS: 1US FAERS
525PriapismFAERS: 1US FAERS
526Product container issueFAERS: 1US FAERS
527Product dose omissionFAERS: 1US FAERS
528Product lot number issueFAERS: 1US FAERS
529Product measured potency issueFAERS: 1US FAERS
530Product packaging confusionFAERS: 1US FAERS
531Product packaging difficult to openFAERS: 1US FAERS
532Product packaging issueFAERS: 1US FAERS
533Product packaging quantity issueFAERS: 1US FAERS
534Product preparation errorFAERS: 1US FAERS
535Product prescribing errorFAERS: 1US FAERS
536Product residue presentFAERS: 1US FAERS
537Product solubility abnormalFAERS: 1US FAERS
538Product use issueFAERS: 1US FAERS
539Productive CoughFAERS: 1US FAERS
540Protein urine presentFAERS: 1US FAERS
541Prothrombin level abnormalFAERS: 1US FAERS
542Pulmonary InfarctionFAERS: 1US FAERS
543Pulmonary function test decreasedFAERS: 1US FAERS
544Pulmonary toxicityFAERS: 1US FAERS
545Pupillary light reflex tests abnormalFAERS: 1US FAERS
546Purulent dischargeFAERS: 1US FAERS
547RadiculopathyFAERS: 1US FAERS
548Reaction to azo-dyesFAERS: 1US FAERS
549Reaction to excipientFAERS: 1US FAERS
550Rebound effectFAERS: 1US FAERS
551Reduced facial expressionFAERS: 1US FAERS
552RegurgitationFAERS: 1US FAERS
553Renal Cell CarcinomaFAERS: 1US FAERS
554Renal ColicFAERS: 1US FAERS
555Renal painFAERS: 1US FAERS
556SarcoidosisFAERS: 1US FAERS
557SarcomaFAERS: 1US FAERS
558ScabFAERS: 1US FAERS
559Serotonin SyndromeFAERS: 1US FAERS
560Sexual DysfunctionFAERS: 1US FAERS
561ShockFAERS: 1US FAERS
562Skin UlcerFAERS: 1US FAERS
563Skin WrinklingFAERS: 1US FAERS
564Slow response to stimuliFAERS: 1US FAERS
565Small intestine carcinomaFAERS: 1US FAERS
566Spina BifidaFAERS: 1US FAERS
567SplenomegalyFAERS: 1US FAERS
568SpondylolisthesisFAERS: 1US FAERS
569Spousal AbuseFAERS: 1US FAERS
570Squamous cell carcinoma of skinFAERS: 1US FAERS
571Squamous cell carcinomaFAERS: 1US FAERS
572StarvationFAERS: 1US FAERS
573StressFAERS: 1US FAERS
574Suspected product tamperingFAERS: 1US FAERS
575SyringomyeliaFAERS: 1US FAERS
576TachyphreniaFAERS: 1US FAERS
577Therapeutic product effect prolongedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
578Therapy cessationFAERS: 1US FAERS
579Therapy non-responderFAERS: 1US FAERS
580ThirstFAERS: 1US FAERS
581Thoracic vertebral fractureFAERS: 1US FAERS
582Throat cancerFAERS: 1US FAERS
583ThrombocytopeniaFAERS: 1US FAERS
584Tooth InfectionFAERS: 1US FAERS
585Tooth LossFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
586Transcription medication errorFAERS: 1US FAERS
587Tumour haemorrhageFAERS: 1US FAERS
588Urinary IncontinenceFAERS: 1US FAERS
589Urine cannabinoids increasedFAERS: 1US FAERS
590Urobilin urine presentFAERS: 1US FAERS
591Uterine CancerFAERS: 1US FAERS
592Walking aid userFAERS: 1US FAERS
593Wound abscessFAERS: 1US FAERS
594Wound infection staphylococcalFAERS: 1US FAERS
595colonoscopyFAERS: 1US FAERS
596muscle injuryFAERS: 1US FAERS
597treatment failureFAERS: 1US FAERS
598Erythema MultiformeCanada Vigilance: 1Canada Vigilance
599Exposure via breast milkCanada Vigilance: 1Canada Vigilance
600Therapeutic product effect incompleteCanada Vigilance: 5Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.